Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings

SIMPLE SUMMARY: Prostate cancer (PCa) patient mortality rates remain high in patients with aggressive disease and the overtreatment of indolent tumors remains a major issue. Prostate-specific antigen (PSA), a standard PCa blood biomarker, is limited in its ability to differentiate disease subtypes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gironda, Daniel J., Bergan, Raymond C., Alpaugh, R. Katherine, Danila, Daniel C., Chuang, Tuan L., Hurtado, Brenda Y., Ho, Thai, Adams, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378487/
https://www.ncbi.nlm.nih.gov/pubmed/37509385
http://dx.doi.org/10.3390/cancers15143725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378487/
https://www.ncbi.nlm.nih.gov/pubmed/37509385
http://dx.doi.org/10.3390/cancers15143725

Ejemplares similares